Floatz logo

Allocetra-Ots

Community-acquired Pneumonia

Enlivex Therapeutics Ltd.Phase 2Dormant
CCC
55/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
40/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Community-acquired Pneumonia cohort.

Asset / SponsorPhaseRating
Linezolid
University Ghent
Phase 4BB
Ap-Pa02
Armata Pharmaceuticals, Inc.
Phase 2BB
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
Denver Health and Hospital Authority
Phase 4BB
Amikacin
Asian Institute of Gastroenterology, India
Phase 4BB
Penicillin
National Heart, Lung, and Blood Institute (NHLBI)
Phase 3BB

View all 26 →

Same molecule, other indications

Allocetra-Ots is also rated in:

acute cholecystitisDormant
CCC
Indicative ·
55 / 100
View asset →
infectious disease with sepsisDormant
CCC
Indicative ·
55 / 100
View asset →
urinary tract infectionDormant
CCC
Indicative ·
55 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →